STOCK TITAN

ORA (NYSE: ORA) files Form 144 showing planned sales of equity types

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ORA: Form 144 notice reporting intended sale of securities. The filing lists securities to be sold on 05/13/2026 on the NYSE, including Common stock, Performance and Restricted Stock (date listed 05/12/2024), and Stock Appreciation Rights (date listed 05/13/2026). The filing records an amount $1,235,387.58 and numeric entries of 9429, 8930, and 499 associated with listed securities.

Positive

  • None.

Negative

  • None.

Insights

Notice documents planned resale of multiple equity instruments on the NYSE.

The excerpt lists Common stock, Performance and Restricted Stock, and Stock Appreciation Rights with dates 05/12/2024 and 05/13/2026. It records $1,235,387.58 and several numeric identifiers.

Cash‑flow treatment and precise share counts tied to those numeric entries are not detailed in the excerpt; subsequent filings or transaction confirmations will show execution specifics and purchaser/underwriter roles.

Filing date listed 05/13/2026 date associated with securities to be sold
Recorded amount $1,235,387.58 amount shown in the excerpt
Numeric identifier 9429 listed alongside Common security entry
Numeric identifier 8930 listed alongside Performance and Restricted Stock entry
Numeric identifier 499 listed alongside Stock Appreciation Rights entry
Stock Appreciation Rights financial
"Common | 05/13/2026 | Stock Appreciation Rights | ISSUER"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
Performance and Restricted Stock financial
"Common | 05/12/2024 | Performance and Restricted Stock | ISSUER"
ISSUER regulatory
"Performance and Restricted Stock | ISSUER"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ORA's Form 144 report?

It reports intended sales of securities including Common stock, Performance and Restricted Stock, and Stock Appreciation Rights on 05/13/2026. The filing lists numeric entries and an amount of $1,235,387.58.

Which securities types are listed in the Form 144 for ORA?

The filing lists Common stock, Performance and Restricted Stock (date 05/12/2024), and Stock Appreciation Rights (date 05/13/2026). It identifies these as issued by the ISSUER.

Does the Form 144 show where the sales will occur?

Yes; the excerpt indicates the sales are listed for the NYSE. The document does not provide execution details such as broker-dealers or sale methods within the provided excerpt.

How much value is recorded in this excerpt of ORA's Form 144?

The excerpt shows an amount of $1,235,387.58 tied to the filing. The context for that amount (proceeds, fair market value, or filing fee basis) is not specified in the excerpt.

Are exact share counts provided in the excerpt?

The excerpt includes numeric entries (9429, 8930, 499) that appear alongside listed securities. The filing does not label these explicitly as total outstanding or specific share counts in the provided text.